EXICURE, INC. Payments to Acquire Debt Securities, Available-for-sale
EXICURE, INC. (XCUR) reported Payments to Acquire Debt Securities, Available-for-sale of $2.09 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-03-25
- EXICURE, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2024-12-31 was $0.00.
- EXICURE, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2024-09-30 was $0.00.
- EXICURE, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2023-12-31 was $0.00.
- EXICURE, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2023-09-30 was $0.00.
- EXICURE, INC. payments to acquire debt securities, available-for-sale for fiscal 2025 was $2.09M.
- EXICURE, INC. payments to acquire debt securities, available-for-sale for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- EXICURE, INC. payments to acquire debt securities, available-for-sale for fiscal 2023 was $2.00M, a 33.42% increase from fiscal 2022.
- EXICURE, INC. payments to acquire debt securities, available-for-sale for fiscal 2022 was $1.50M, a 76.93% decline from fiscal 2021.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 6 month as first filed | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $2.09M 10-K · filed 2026-03-25 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $0.00 derived: sum of 2 quarters · filed 2025-03-18 | $2.00M derived: sum of 3 quarters · filed 2025-03-18 | $2.00M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $2.00M derived: sum of 2 quarters · filed 2024-11-14 | $2.00M 10-Q · filed 2024-11-14 | $2.00M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $2.00M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-08-13 | $2.00M 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2023-08-11 | $2.00M derived: sum of 3 quarters · filed 2024-08-13 | $2.00M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $0.00 10-Q/A · filed 2024-06-06 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $0.00 derived: sum of 4 quarters · filed 2024-06-06 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $1.50M 10-K · filed 2024-06-06 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $1.50M 10-Q · filed 2024-05-16 | $1.50M derived: sum of 4 quarters · filed 2024-06-06 | |
| 2022-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | $1.50M 10-Q/A · filed 2024-06-06 | $1.50M derived: sum of 3 quarters · filed 2024-06-06 | $6.00M derived: sum of 4 quarters · filed 2024-06-06 | |
| 2022-03-31 | $1.50M 10-Q/A · filed 2024-06-06 | $1.50M derived: sum of 2 quarters · filed 2024-06-06 | $6.00M derived: sum of 3 quarters · filed 2024-06-06 | $8.00M derived: sum of 4 quarters · filed 2024-06-06 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $4.50M derived: sum of 2 quarters · filed 2023-03-27 | $6.50M derived: sum of 3 quarters · filed 2023-03-27 | $6.50M 10-K · filed 2023-03-27 | |
| 2021-09-30 | $4.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $6.50M derived: sum of 2 quarters · filed 2022-11-14 | $6.50M 10-Q · filed 2022-11-14 | $15.79M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $2.00M 10-Q · filed 2022-08-15 | $11.29M derived: sum of 3 quarters · filed 2022-08-15 | $20.57M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | $9.29M derived: sum of 2 quarters · filed 2022-05-16 | $18.57M derived: sum of 3 quarters · filed 2022-05-16 | $34.71M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $9.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $18.57M derived: sum of 2 quarters · filed 2022-03-25 | $34.71M derived: sum of 3 quarters · filed 2022-03-25 | $56.64M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $9.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | $25.42M derived: sum of 2 quarters · filed 2021-11-19 | $47.35M 10-Q · filed 2021-11-19 | $109.70M derived: sum of 4 quarters · filed 2021-11-19 | |
| 2020-06-30 | $16.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $38.07M 10-Q · filed 2021-08-12 | $100.42M derived: sum of 3 quarters · filed 2021-08-12 | $100.42M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $21.93M 10-Q · filed 2021-05-12 | $84.28M derived: sum of 2 quarters · filed 2021-05-12 | $84.28M derived: sum of 3 quarters · filed 2021-05-12 | $84.28M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | $62.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $62.35M derived: sum of 2 quarters · filed 2021-03-11 | $62.35M derived: sum of 3 quarters · filed 2021-03-11 | $62.35M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $0.00 10-Q · filed 2020-08-12 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 | ||||
| 2018-12-31 | $0.00 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |